Critical considerations in the administration of antineoplastic therapy for patients with malignant solid tumors undergoing hemodialysis
{{output}}
Patients with chronic kidney disease exhibit a higher risk of developing malignancies, and among those with end-stage renal disease (ESRD) on dialysis, approximately 7% are diagnosed with new-onset tumors within five years. Patients with ESRD who are receiving... ...
